147 related articles for article (PubMed ID: 921248)
1. Inactivation and inhibition of replication of the enveloped bacteriophage phi6 by fatty acids.
Sands JA
Antimicrob Agents Chemother; 1977 Oct; 12(4):523-8. PubMed ID: 921248
[TBL] [Abstract][Full Text] [Related]
2. Enveloped virus inactivation by fatty acid derivatives.
Sands JA; Auperin LD; Reinhardt A
Antimicrob Agents Chemother; 1979 Jan; 15(1):134-6. PubMed ID: 218498
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of fatty acids on the entry of the lipid-containing bacteriophage PR4 into Escherichia coli.
Reinhardt A; Cadden S; Sands JA
J Virol; 1978 Feb; 25(2):479-85. PubMed ID: 342724
[TBL] [Abstract][Full Text] [Related]
4. Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols.
Sands J; Auperin D; Snipes W
Antimicrob Agents Chemother; 1979 Jan; 15(1):67-73. PubMed ID: 218499
[TBL] [Abstract][Full Text] [Related]
5. Higher Concentrations of Bacterial Enveloped Virus Phi6 Can Protect the Virus from Environmental Decay.
Bangiyev R; Chudaev M; Schaffner DW; Goldman E
Appl Environ Microbiol; 2021 Oct; 87(21):e0137121. PubMed ID: 34406830
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Phi6 Persistence and Suitability as an Enveloped Virus Surrogate.
Aquino de Carvalho N; Stachler EN; Cimabue N; Bibby K
Environ Sci Technol; 2017 Aug; 51(15):8692-8700. PubMed ID: 28657725
[TBL] [Abstract][Full Text] [Related]
7. Effects of temperature and host cell genetic characteristics on the replication of the lipid-containing bacteriophage PR4 in Escherichia coli.
Sands JA; Auperin D
J Virol; 1977 May; 22(2):315-20. PubMed ID: 325229
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the enveloped virus phi6 with hydrodynamic cavitation.
Zupanc M; Zevnik J; Filipić A; Gutierrez-Aguirre I; Ješelnik M; Košir T; Ortar J; Dular M; Petkovšek M
Ultrason Sonochem; 2023 May; 95():106400. PubMed ID: 37060711
[TBL] [Abstract][Full Text] [Related]
9. Dual Role of a Viral Polymerase in Viral Genome Replication and Particle Self-Assembly.
Sun X; Ilca SL; Huiskonen JT; Poranen MM
mBio; 2018 Oct; 9(5):. PubMed ID: 30279282
[TBL] [Abstract][Full Text] [Related]
10. The origin of phospholipids of the enveloped bacteriophage phi6.
Laurinavicius S; Käkelä R; Bamford DH; Somerharju P
Virology; 2004 Aug; 326(1):182-90. PubMed ID: 15262506
[TBL] [Abstract][Full Text] [Related]
11. Bacteriophage phi6: a Lipid-Containing Virus of Pseudomonas phaseolicola.
Vidaver AK; Koski RK; Van Etten JL
J Virol; 1973 May; 11(5):799-805. PubMed ID: 16789137
[TBL] [Abstract][Full Text] [Related]
12. Microbial production of lipid-protein vesicles using enveloped bacteriophage phi6.
Lyytinen OL; Starkova D; Poranen MM
Microb Cell Fact; 2019 Feb; 18(1):29. PubMed ID: 30732607
[TBL] [Abstract][Full Text] [Related]
13. Studies with a hydrophobic, spin-labeled virucidal agent.
DeLuca N; Keith A; Snipes W
Antimicrob Agents Chemother; 1980 Jan; 17(1):63-70. PubMed ID: 6243452
[TBL] [Abstract][Full Text] [Related]
14. Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes.
Davis FB; Davis PJ; Blas SD; Schoenl M
Biochem J; 1987 Dec; 248(2):511-6. PubMed ID: 2963620
[TBL] [Abstract][Full Text] [Related]
15. Heteroaggregation of an enveloped bacteriophage with colloidal sediments and effect on virus viability.
Katz A; Peña S; Alimova A; Gottlieb P; Xu M; Block KA
Sci Total Environ; 2018 Oct; 637-638():104-111. PubMed ID: 29747115
[TBL] [Abstract][Full Text] [Related]
16. Effect of fatty acids on growth of Japanese encephalitis virus cultivated in BHK-21 cells and phospholipid metabolism of the infected cells.
Makino S; Jenkin HM
J Virol; 1975 Mar; 15(3):515-25. PubMed ID: 1167607
[TBL] [Abstract][Full Text] [Related]
17. Individual saturated fatty acids and effects on whole blood aggregation in vitro.
Temme EH; Mensink RP; Hornstra G
Eur J Clin Nutr; 1998 Oct; 52(10):697-702. PubMed ID: 9805214
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of nano-monocaprin against Phi6 as a surrogate for SARS-CoV-2.
Sorinolu AJ; Mamun MM; Vadarevu H; Vivero-Escoto JL; Vejerano EP; Munir M
Int Microbiol; 2023 May; 26(2):379-387. PubMed ID: 36422769
[TBL] [Abstract][Full Text] [Related]
19. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses.
Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL; Csizmadia F
Antiviral Res; 1997 May; 34(3):75-90. PubMed ID: 9191015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
